Bulletin
Investor Alert

Perrigo Co. PLC

NYS: PRGO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 6, 2021, 5:29 p.m.

/zigman2/quotes/201110862/composite

$

37.04

Change

0.00 0.00%

Volume

Volume 32,098

Quotes are delayed by 20 min

/zigman2/quotes/201110862/composite

Today's close

$ 35.79

$ 37.04

Change

+1.25 +3.49%

Day low

Day high

$36.04

$38.04

Open

52 week low

52 week high

$35.34

$50.90

Open

Rolf Allan Classon

Rolf Classon, Operating Partner

Rolf Classon is an Operating Partner at FACP and FAPI focused on Life Sciences and Medical Technology.

Prior to joining FACP in 2017, Rolf was a Senior Advisor at Brown Brothers Harriman (BBH) Capital Partners, which he joined in 2015. Prior to BBH, he was the senior Operating Partner in life sciences at Health Evolution Partners, since 2011. Previously, Rolf held various management positions within Bayer AG, including as Chairman of the Executive Committee of its subsidiary Bayer HealthCare AG, until his retirement from the company in 2004.

Rolf currently serves as Chairman of the Board of Directors of Perrigo and as a member of the Board of Directors of Fresenius Medical Care, Catalent and Freedom Innovations.

Rolf received his chemical engineering certificate from the Gothenburg School of Engineering and a business degree from Gothenburg University.

Transactions

Date Shares Transaction Value
05/07/2021 3,483   Derivative/Non-derivative trans. at $42.96 per share. 149,630
05/07/2021 7,255   Derivative/Non-derivative trans. at $42.96 per share. 311,674
11/09/2020 2,137   Acquisition at $46.75 per share. 99,904
05/15/2020 3,633   Derivative/Non-derivative trans. at $52.76 per share. 191,678
05/15/2020 7,568   Derivative/Non-derivative trans. at $52.76 per share. 399,287
05/15/2019 2,383   Derivative/Non-derivative trans. at $49.55 per share. 118,078
05/15/2019 4,964   Derivative/Non-derivative trans. at $49.55 per share. 245,966
06/06/2018 2,048   Derivative/Non-derivative trans. at $73.22 per share. 149,955
06/06/2018 4,265   Derivative/Non-derivative trans. at $73.22 per share. 312,283

Officers and Executives

Mr. Murray S. Kessler
President, Chief Executive Officer & Director
Mr. Raymond P. Silcock
CFO, Principal Accounting Officer & Executive VP
Mr. Thomas M. Farrington
Chief Information Officer & Executive VP
Dr. Grainne Quinn
Chief Medical Officer & Executive Vice President
Mr. Adrian Innergård
General Manager-Northern Europe
Ms. Sharon Kochan
EVP, President-RX Pharmaceuticals
Mr. Svend D. Andersen
EVP & President-Consumer Selfcare International
Mr. Ronald C. Janish
Chief Transformation Officer
Mr. James E. Dillard
President-CSCA & Executive Vice President
Mr. Louis K. Cherico
Treasurer & Vice President
Mr. Bradley Joseph
Vice President-Global Investor Relations
Mr. Robert Willis
Chief Human Resources Officer & Executive VP
Mr. Todd W. Kingma
Secretary, Executive VP & General Counsel
Mr. Rolf Allan Classon
Chairman
Ms. Katherine C. Doyle
Independent Director
Mr. Orlando D. Ashford
Independent Director
Mr. Donal M. O'Connor
Independent Director
Mr. Geoffrey M. Parker
Independent Director
Mr. Theodore Rapp Samuels
Independent Director
Mr. Bradley A. Alford
Independent, Director
Mr. Jeffrey B. Kindler
Independent Director
Ms. Adriana Karaboutis
Independent Director
Ms. Erica L. Mann
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.